Detalhe da pesquisa
1.
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management.
J Am Acad Dermatol
; 90(5): 911-926, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37516356
2.
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.
J Am Acad Dermatol
; 90(5): 885-908, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37516359
3.
Validation of alopecia coding in US claims data among women of childbearing age.
Pharmacoepidemiol Drug Saf
; 33(4): e5782, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38566351
4.
Evaluation of Inclusion and Exclusion Criteria for Pyoderma Gangrenosum in Clinical Research: A Systematic Review.
Dermatology
; 240(1): 26-31, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879301
5.
Mortality and Autopsy Findings in Patients with Pyoderma Gangrenosum: A Multi-Institutional Series.
Dermatology
; 240(2): 352-356, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38185115
6.
Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials.
Br J Dermatol
; 188(2): 218-227, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763878
7.
Effective counseling of patients with hair loss.
J Am Acad Dermatol
; 89(2S): S40-S42, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37591566
8.
Complementary and alternative medicine for alopecia areata: A systematic review.
J Am Acad Dermatol
; 88(1): 131-143, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31870916
9.
Monkeypox outbreak, vaccination, and treatment implications for the dermatologic patient: Review and interim guidance from the Medical Dermatology Society.
J Am Acad Dermatol
; 88(3): 623-631, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36528266
10.
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer.
Curr Treat Options Oncol
; 24(4): 373-379, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36917395
11.
Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis.
Pharmacoepidemiol Drug Saf
; 32(5): 567-576, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36527432
12.
Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis.
Acta Derm Venereol
; 103: adv12445, 2023 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37622204
13.
Seasonal Patterns in Tetracycline-Associated Hyperpigmentation Among Patients With Acne Vulgaris.
J Drugs Dermatol
; 22(11): e9-e11, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37943268
14.
International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual Meeting.
J Drugs Dermatol
; 22(12): 1153-1159, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051841
15.
Longitudinal utilization of systemic immunomodulators before and after dupilumab approval in children with atopic dermatitis.
Pediatr Dermatol
; 40(1): 132-134, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36403606
16.
Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: Epidemiology.
Br J Dermatol
; 187(5): 692-703, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35718888
17.
International Dermatology Outcome Measures (IDEOM): Report from the 2021 Annual Meeting.
J Drugs Dermatol
; 21(8): 867-874, 2022 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35946973
18.
Delayed medical care due to transportation barriers among US children with atopic dermatitis.
Pediatr Dermatol
; 39(6): 927-930, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36004673
19.
Crowdfunding for Gender-Affirming Mastectomy: Balancing Fundraising With Loss of Privacy.
Ann Plast Surg
; 88(4): 372-374, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34270468
20.
Geographic disparities in access to scalp cooling for the prevention of chemotherapy-induced alopecia in the United States.
J Am Acad Dermatol
; 85(5): 1248-1252, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32610170